Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2018 04; 20(4):760-768.

View in: PubMed

subject areas

Aged
Aminobutyrates
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Biphenyl Compounds
Dose-Response Relationship, Drug
Drug Combinations
Enalapril
Europe
Female
Heart Failure
Humans
Male
Middle Aged
Morbidity
Prospective Studies
Recurrence
Stroke Volume
Survival Rate
Tetrazoles
United States
Valsartan

authors with profiles

Michael R. Zile